Prawo i regulacje · 21/10/2011

DEA Proposes Placing Ezogabine in Schedule V of Controlled Substances Act

The Drug Enforcement Administration (DEA) is proposing to place ezogabine, including its salts and isomers, into Schedule V of the Controlled Substances Act (CSA), a requirement under the CSA that necessitates a formal rulemaking process.